United Therapeutics | Beneficio Bruto En Ventas



Gross Profit On Sales Cambio Fecha
Amarin USD 25.13M 1.78M 2025-03
Ardelyx USD 82.84M 15.02M 2025-06
Baxter International USD 1.14B 283M 2025-06
Bayer EUR 6.38B 1.74B 2025-06
Biogen USD 2.04B 238.8M 2025-06
BioMarin Pharmaceutical USD 670.47M 76.89M 2025-06
Gilead Sciences USD 5.58B 453M 2025-06
GlaxoSmithKline GBP 5.82B 229M 2025-06
Halozyme Therapeutics USD 279.36M 62.9M 2025-06
Insmed USD 78.08M 6.53M 2025-06
Ionis Pharmaceuticals USD 448M 317.85M 2025-06
J&J USD 14.6B 816M 2025-03
Moderna USD 18M 1000K 2025-06
Pfizer USD 10.88B 248M 2025-06
PTC Therapeutics USD 163.39M 999.84M 2025-06
Regeneron Pharmaceuticals USD 3.15B 581M 2025-06
Sarepta Therapeutics USD 457.87M 149.43M 2025-06
Teva Pharmaceutical Industries USD 2.1B 188M 2025-06
United Therapeutics USD 711M 9.1M 2025-06
Vertex Pharmaceuticals USD 2.56B 150M 2025-06


United Therapeutics Beneficio Bruto En Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Sep 2025.